Fundraising Overview - The company, Jiangsu Jicui Yaokang Biotechnology Co., Ltd., has been approved to publicly issue 50 million shares at a price of RMB 10.03979 million, resulting in a net fundraising amount of RMB 1,026.1021 million after deducting issuance costs [1][2] - The funds have been fully received and verified by the accounting firm, with a verification report issued on April 19, 2022 [1] Fund Management and Regulatory Compliance - The company has established a special account for the management of the raised funds and signed a regulatory agreement with the sponsor, Huatai United Securities Co., Ltd., and the bank managing the special account [2][3] - A board meeting and a shareholder meeting were held to approve the allocation of RMB 200 million for a new project focused on "AI-driven organ and animal disease model multimodal preclinical drug research platform" [2][3] Special Account and Agreement Details - The special account has been opened at China Merchants Bank, Nanjing Branch, specifically for the new project [3] - The agreement stipulates that the funds in the special account must only be used for the designated project and outlines the responsibilities of all parties involved, including the sponsor's oversight role [4][5] Oversight and Reporting - The sponsor is required to monitor the use of the funds and conduct semi-annual checks on the account [4][5] - The bank must provide monthly account statements to both the company and the sponsor, ensuring transparency in fund management [5] Agreement Validity and Termination - The agreement will remain in effect until all funds are fully utilized and the account is closed, with provisions for termination in case of non-compliance [6]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688046 证券简称：药康生物 公告编号：2025-014 江苏集萃药康生物科技股份有限公司 关于使用闲置自有资金 进行委托理财的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 江苏集萃药康生物科技股份有限公司（以下简称"公司"）于 2025 年 4 月 7 日召开第二届董事会第十次 会议、第二届监事会第九次会议，审议了《关于使用闲置自有资金进行委托理财的议案》，一致同意公 司在不影响正常经营的情况下，使用不超过人民币 7 亿元（含本数）自有闲置资金进行委托理财，有效 期自董事会审议通过之日起至下一年度董事会审议使用闲置自有资金进行委托理财事项之日止，如单笔 交易的有效期超过决议的有效期，则决议的有效期自动顺延至单笔交易终止时止。在上述额度及有效期 内，资金可循环滚动使用。董事会授权总经理或其授权人士行使投资决策权并签署相关法律文件，由公 司财务部及资金部具体实施相关事宜，本事项无需提交公司股东大会审议。现将相关情况公告如下： 一、使用闲置自有资金进行委托 ...